Literature DB >> 17701180

Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI.

Rosemarie Forstner1.   

Abstract

Ovarian cancer is the most lethal among the gynecologic malignancies with approximately 70% of patients presenting with advanced tumor stage. The prognosis of patients with ovarian cancer is directly related to the tumor stage and residual tumor burden after cytoreductive surgery. Exploratory laparotomy has been the cornerstone in the management of ovarian cancer, as it offers staging and tumor debulking. Understaging at initial laparotomy, however, is a problem in up to 30%, mainly due to insufficient technique and unexpected peritoneal spread outside the pelvis. Sites difficult to assess intraoperatively including the posterior aspect of the liver and the dome of the diaphragm can be well demonstrated with multiplanar imaging. CT and alternatively MRI have been accepted as adjunct imaging modalities for preoperative staging ovarian cancer. Of these, multidetector CT is the imaging modality of choice for staging ovarian cancer. In a multidisciplinary team approach patient management may be guided towards an individualized treatment plan. The contribution of imaging includes (1) surgery planning including referral practice, (2) selection of candidates for primary chemotherapy by demonstration of non (optimally) resectable disease, and (3) tissue sampling in peritoneal carcinomatosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701180     DOI: 10.1007/s00330-007-0736-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  53 in total

1.  Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.

Authors:  M Böhm-Vélez; E Mendelson; R Bree; H Finberg; E K Fishman; H Hricak; F Laing; D Sartoris; A Thurmond; S Goldstein
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  A multidisciplinary approach to ovarian cancer at diagnosis.

Authors:  J A Spencer
Journal:  Br J Radiol       Date:  2005       Impact factor: 3.039

3.  The significance of paracardiac lymph node enlargement in ovarian cancer.

Authors:  B J Holloway; M E Gore; R P A'Hern; C Parsons
Journal:  Clin Radiol       Date:  1997-09       Impact factor: 2.350

Review 4.  Fertility preservation options for women with malignancies.

Authors:  Enbal Marhhom; Ilan Cohen
Journal:  Obstet Gynecol Surv       Date:  2007-01       Impact factor: 2.347

Review 5.  Ovarian cancer.

Authors:  Nicoletta Colombo; Toon Van Gorp; Gabriella Parma; Frederic Amant; Gemma Gatta; Cristiana Sessa; Ignace Vergote
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-02       Impact factor: 6.312

6.  Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group.

Authors:  A B Kurtz; J V Tsimikas; C M Tempany; U M Hamper; P H Arger; R L Bree; R J Wechsler; I R Francis; J E Kuhlman; E S Siegelman; D G Mitchell; S G Silverman; D L Brown; S Sheth; B G Coleman; J H Ellis; R J Kurman; D J Caudry; B J McNeil
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

Review 7.  The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.

Authors:  J Huober; A Meyer; U Wagner; D Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2002-01-29       Impact factor: 4.553

8.  Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer.

Authors:  P Benedetti-Panici; S Greggi; F Maneschi; G Scambia; M Amoroso; C Rabitti; S Mancuso
Journal:  Gynecol Oncol       Date:  1993-11       Impact factor: 5.482

9.  Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.

Authors:  B E Nelson; A T Rosenfield; P E Schwartz
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

Review 10.  Staging ovarian cancer: role of imaging.

Authors:  Fergus V Coakley
Journal:  Radiol Clin North Am       Date:  2002-05       Impact factor: 2.303

View more
  23 in total

Review 1.  ESUR guidelines: ovarian cancer staging and follow-up.

Authors:  Rosemarie Forstner; Evis Sala; Karen Kinkel; John A Spencer
Journal:  Eur Radiol       Date:  2010-09-14       Impact factor: 5.315

Review 2.  Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.

Authors:  Samdeep K Mouli; Ramona Gupta; Neil Sheth; Andrew C Gordon; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

Review 3.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

Review 4.  Unexpected gynecologic findings during abdominal surgery.

Authors:  Casey A Boyd; Taylor S Riall
Journal:  Curr Probl Surg       Date:  2012-04       Impact factor: 1.909

5.  Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.

Authors:  Katrijn L M Michielsen; Ignace Vergote; Raphaëla Dresen; Katya Op de Beeck; Ragna Vanslembrouck; Frédéric Amant; Karin Leunen; Philippe Moerman; Steffen Fieuws; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Br J Radiol       Date:  2016-09-21       Impact factor: 3.039

6.  HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma.

Authors:  Cecilia Midulla; Lucia Manganaro; Flavia Longo; Valentina Viggiani; Luigi Frati; Teresa Granato; Emanuela Anastasi
Journal:  Tumour Biol       Date:  2012-03-20

Review 7.  Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: Part 2.

Authors:  Celine D Alt; Kerstin A Brocker; Michael Eichbaum; Christof Sohn; Florian U Arnegger; Hans-Ulrich Kauczor; Peter Hallscheidt
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

Review 8.  Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery.

Authors:  Soo Young Jeong; Tae Joong Kim; Byung Kwan Park
Journal:  J Gynecol Oncol       Date:  2020-04-13       Impact factor: 4.401

9.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Authors:  Katrijn Michielsen; Ignace Vergote; Katya Op de Beeck; Frederic Amant; Karin Leunen; Philippe Moerman; Christophe Deroose; Geert Souverijns; Steven Dymarkowski; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Eur Radiol       Date:  2013-12-11       Impact factor: 5.315

10.  Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.